concomitant asm dose reductions in clinical trial of adjunctive cenobamate for focal seizures
Published 2 years ago • 105 plays • Length 1:11Download video MP4
Download video MP3
Similar videos
-
1:40
long-term efficacy of adjunctive cenobamate in patients with focal seizures
-
2:23
cenobamate therapy reduces concomitant drug load in patients with epilepsy
-
7:02
how to manage patients receiving adjunctive cenobamate
-
2:38
clinical characteristics of patients achieving seizure freedom with adjunctive cenobamate
-
7:01
early and sustained responses to cenobamate across focal seizure subtypes
-
4:37
cenobamate in different epilepsy populations & with different medications
-
3:14
challenges with cenobamate use in focal epilepsy
-
2:41
predictors of maintained response to cenobamate in patients with epilepsy
-
8:56
long-term efficacy of cenobamate in patients with uncontrolled focal seizures
-
5:29
post-hoc analysis of c017: efficacy and safety of cenobamate
-
2:55
cenobamate for focal seizures: longer-term efficacy and adverse events
-
5:36
how will the role of cenobamate evolve in the epilepsy space?
-
9:07
practical recommendations on cenobamate for epilepsy
-
7:19
sudep rates in the cenobamate development program
-
6:27
cenobamate as a promising treatment for patients with epilepsy
-
2:13
aan 2020 clinical trial data: uncontrolled focal seizures
-
1:59
what is behind cenobamate’s remarkable efficacy against focal-onset seizures?
-
6:15
cenobamate shows long-term benefits for focal seizures
-
1:16
insights from cenobamate studies